Malignant Peripheral Nerve Sheath Tumors

Neurosurgery Clinics of North America

Volumn 19, Issue 4, 2008, Pages 533-543

  Gupta, Gaurav ^a   Mammis, Antonios ^a   Maniker, Allen ^b  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Diagnosis; Peripheral nerve sheath tumors; Treatment

Indexed keywords

CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; IFOSFAMIDE; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RISK; CELL LINE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; HUMAN; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; NERVE SHEATH TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERIPHERAL NERVE; PERIPHERAL NERVE SHEATH TUMOR; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; HUMANS; MAGNETIC RESONANCE IMAGING; NERVE SHEATH NEOPLASMS; PERIPHERAL NERVOUS SYSTEM NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RISK FACTORS;

EID: 55749112120     PISSN: 10423680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nec.2008.07.004     Document Type: Review

References (76)

1. Dasgupta T., and Chaudhuri P. Tumors of soft tissue. 2nd edition (1998), Appleton and Lange, Connecticut
2. Wanebo J.E., Malik J.M., VandenBerg S.R., et al. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer 71 4 (1993) 1247-1253
3. D'Agostino A.N., Soule E.H., and Miller R.H. Sarcomas of the peripheral nerves and somatic soft tissues associated with multiple neurofibromatosis (Von Recklinghausen's disease). Cancer 16 (1963) 1015-1027
4. Cashen D.V., Parisien R.C., Raskin K., et al. Survival data for patients with malignant schwannoma. Clin Orthop Relat Res 426 (2004) 69-73
5. Hirose T., Scheithauer B.W., and Sano T. Perineurial malignant peripheral nerve sheath tumor (MPNST): a clinicopathologic, immunohistochemical, and ultrastructural study of seven cases. Am J Surg Pathol 22 11 (1998) 1368-1378
6. Baehring J., Betensky R., and Batchelor T. Malignant peripheral nerve sheath tumor: the clinical spectrum and outcome of treatment. Neurology 61 5 (2003) 696-698
7. Stout A. The peripheral manifestation of the specific nerve sheath tumor (neurilemoma). Am J Cancer 24 (1935) 751-796
8. Woodruff J.M. Arthur Purdy Stout and the evolution of modern concepts regarding peripheral nerve sheath tumors. Am J Surg Pathol 10 Suppl 1 (1986) 63-67
9. Stout A. Tumors of peripheral nervous system. vol. sect. 2, fasc. 6 (1949), Armed Forces Institute of Pathology, Washington, DC
10. Hadju S. Peripheral nerve sheath tumors. Histogenesis, classification, and prognosis. [editorial]. Cancer 72 12 (1993) 3549-3552
11. Angelov L., Davis A., O'Sullivan B., et al. Neurogenic sarcomas: experience at the University of Toronto. Neurosurgery 43 1 (1998) 56-64 [discussion: 64-5]
12. Evans D.G., Baser M.E., McGaughran J., et al. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 39 5 (2002) 311-314
13. Ducatman B.S., Scheithauer B.W., Piepgras D.G., et al. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 57 10 (1986) 2006-2021
14. Tucker T., Wolkenstein P., Revuz J., et al. Association between benign and malignant peripheral nerve sheath tumors in NF1. Neurology 65 2 (2005) 205-211
15. Bergstrom R. Morphological studies on peripheral nerves exposed to a beam of high energy protons. Acta Pathol Microbiol Scand Suppl Suppl 154 (1962) 80-82
16. Cavanagh J.B. Effects of x-irradiation on the proliferation of cells in peripheral nerve during Wallerian degeneration in the rat. Br J Radiol 41 484 (1968) 275-281
17. Wong W.W., Hirose T., Scheithauer B.W., et al. Malignant peripheral nerve sheath tumor: analysis of treatment outcome. Int J Radiat Oncol Biol Phys 42 2 (1998) 351-360
18. Kourea H.P., Bilsky M.H., Leung D.H., et al. Subdiaphragmatic and intrathoracic paraspinal malignant peripheral nerve sheath tumors: a clinicopathologic study of 25 patients and 26 tumors. Cancer 82 11 (1998) 2191-2203
19. D'Agostino A.N., Soule E.H., and Miller R.H. Primary malignant neoplasms of nerves (malignant neurilemomas) in patients without manifestations of multiple neurofibromatosis (Von Recklinghausen's disease). Cancer 16 (1963) 1003-1014
20. Loree T.R., North Jr. J.H., Werness B.A., et al. Malignant peripheral nerve sheath tumors of the head and neck: analysis of prognostic factors. Otolaryngol Head Neck Surg 122 5 (2000) 667-672
21. Amin A., Saifuddin A., Flanagan A., et al. Radiotherapy-induced malignant peripheral nerve sheath tumor of the cauda equina. Spine 29 21 (2004) E506-E509
22. Kim H.J., Kim C.H., Kim H., et al. Malignant peripheral nerve sheath tumour of the paranasal sinus. J Otolaryngol 36 3 (2007) E9-E11
23. Fukushima S., Kageshita T., Wakasugi S., et al. Giant malignant peripheral nerve sheath tumor of the scalp. J Dermatol 33 12 (2006) 865-868
24. Kumar P., Jaiswal S., Agrawal T., et al. Malignant peripheral nerve sheath tumor of the occipital region: case report. Neurosurgery 61 6 (2007) E1334-E1335 [discussion: E1335]
25. Strauss L.G., and Conti P.S. The applications of PET in clinical oncology. J Nucl Med 32 4 (1991) 623-648 [discussion: 649-50]
26. Ferner R.E., Lucas J.D., O'Doherty M.J., et al. Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1. J Neurol Neurosurg Psychiatry 68 3 (2000) 353-357
27. Ferner R.E., and Gutmann D.H. International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res 62 5 (2002) 1573-1577
28. Ferner R.E., Golding J.F., Smith M., et al. [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study. Ann Oncol 19 2 (2008) 390-394
29. Nambisan R.N., Rao U., Moore R., et al. Malignant soft tissue tumors of nerve sheath origin. J Surg Oncol 25 4 (1984) 268-272
30. Hruban R.H., Shiu M.H., Senie R.T., et al. Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases. Cancer 66 6 (1990) 1253-1265
31. Vege D.S., Chinoy R.F., Ganesh B., et al. Malignant peripheral nerve sheath tumors of the head and neck: a clinicopathological study. J Surg Oncol 55 2 (1994) 100-103
32. Bhattacharyya A.K., Perrin R., and Guha A. Peripheral nerve tumors: management strategies and molecular insights. J Neurooncol 69 1-3 (2004) 335-349
33. Gachiani J., Kim D., Nelson A., et al. Surgical management of malignant peripheral nerve sheath tumors. Neurosurg Focus 22 6 (2007) E13
34. Russell S.M. Preserve the nerve: microsurgical resection of peripheral nerve sheath tumors. Neurosurgery 61 3 Suppl (2007) 113-117 [discussion: 117-8]
35. Huang J.H., Zager E.H., and Russell S.M. Preserve the nerve: microsurgical resection of peripheral nerve sheath tumors. Comment in. Neurosurgery 61 3 Suppl (2007) 113-117 [discussion: 117-8]
36. Doorn P.F., Molenaar W.M., Buter J., et al. Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis. Eur J Surg Oncol 21 1 (1995) 78-82
37. Brennan M.F. The enigma of local recurrence. The Society of Surgical Oncology. Ann Surg Oncol 4 1 (1997) 1-12
38. Greager J.A., Reichard K.W., Campana J.P., et al. Malignant schwannoma of the head and neck. Am J Surg 163 4 (1992) 440-442
39. Viskochil D., Buchberg A.M., Xu G., et al. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 62 1 (1990) 187-192
40. Wallace M.R., Marchuk D.A., Andersen L.B., et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 249 4965 (1990) 181-186
41. Xu G.F., O'Connell P., Viskochil D., et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62 3 (1990) 599-608
42. LeVay J., O'Sullivan B., Catton C., et al. Outcome and prognostic factors in soft tissue sarcomas in the adult. Int J Radiat Oncol Biol Phys 27 (1993) 1091-1099
43. Pisters P., Leung D., Woodruff J., et al. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 14 (1996) 1679-1689
44. Saddegh M.K., Lindholm J., Lundberg A., et al. Staging of soft-tissue sarcomas. Prognostic analysis of clinical and pathological features. J Bone Joint Surg Br 74 4 (1992) 495-500
45. Singer S., Corson J.M., Gonin R., et al. Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma. Ann Surg 219 2 (1994) 165-173
46. Cotran R., Kumar V., and Robbins S. Robbins' pathologic basis of disease (1994), Saunders, Philadelphia
47. Johnson M.D., Glick A.D., and Davis B.W. Immunohistochemical evaluation of Leu-7, myelin basic-protein, S100-protein, glial-fibrillary acidic-protein, and LN3 immunoreactivity in nerve sheath tumors and sarcomas. Arch Pathol Lab Med 112 2 (1988) 155-160
48. Enziger F., and Weiss S. Benign tumors of peripheral nerves: malignant tumors of the peripheral nerves. 4th edition (2001), Mosby, St. Louis (MO)
49. Trojanowski J.Q., Kleinman G.M., and Proppe K.H. Malignant tumors of nerve sheath origin. Cancer 46 5 (1980) 1202-1212
50. Wilson A.N., Davis A., Bell R.S., et al. Local control of soft tissue sarcoma of the extremity: the experience of a multidisciplinary sarcoma group with definitive surgery and radiotherapy. Eur J Cancer 30A 6 (1994) 746-751
51. Hirose T., Hasegawa T., Kudo E., et al. Malignant peripheral nerve sheath tumors: an immunohistochemical study in relation to ultrastructural features. Hum Pathol 23 8 (1992) 865-870
52. Kikuchi A., Akiyama M., Han-Yaku H., et al. Solitary cutaneous malignant schwannoma. Immunohistochemical and ultrastructural studies. Am J Dermatopathol 15 1 (1993) 15-19
53. Matus A., and Mughal S. Immunohistochemical localization of S-100 protein in the brain. Nature 258 (1975) 746-748
54. Moore B.W., and McGregor D. Chromatographic and electrophoretic fractionation of soluble proteins of brain and liver. J Biol Chem 240 (1965) 1647-1653
55. Wick M.R., Swanson P.E., Scheithauer B.W., et al. Malignant peripheral nerve sheath tumor. An immunohistochemical study of 62 cases. Am J Clin Pathol 87 4 (1987) 425-433
56. Yamaguchi U., Hasegawa T., Hirose T., et al. Low grade malignant peripheral nerve sheath tumour: varied cytological and histological patterns. J Clin Pathol 56 11 (2003) 826-830
57. Zhou H., Coffin C.M., Perkins S.L., et al. Malignant peripheral nerve sheath tumor: a comparison of grade, immunophenotype, and cell cycle/growth activation marker expression in sporadic and neurofibromatosis 1-related lesions. Am J Surg Pathol 27 10 (2003) 1337-1345
58. Feldkamp M.M., Lau N., Provias J.P., et al. Acute presentation of a neurogenic sarcoma in a patient with neurofibromatosis type 1: a pathological and molecular explanation. Case report. J Neurosurg 84 5 (1996) 867-873
59. King R., Busam K., and Rosai J. Metastatic malignant melanoma resembling malignant peripheral nerve sheath tumor: report of 16 cases. Am J Surg Pathol 23 12 (1999) 1499-1505
60. Bilge B., Ates L.E., Demiryont M., et al. Malignant peripheral nerve sheath tumors associated with neurofibromatosis Type 1. Pathol Oncol Res 9 (2000) 201-205
61. Weiss S., and Goldblum J. Soft tissue tumors. 4th edition (2001), Mosby Co, St. Louis (MO)
62. Suh J.S., Abenoza P., Galloway H.R., et al. Peripheral (extracranial) nerve tumors: correlation of MR imaging and histologic findings. Radiology 183 2 (1992) 341-346
63. Neilson O., Cummings B., O'Sullivan B., et al. Comparison of treatment volumes in preoperative and postoperative irradiation for soft tissue sarcomas. Int J Radiat Oncol Biol Phys 21 (1991) 1595-1599
64. Peat B., Bell R., Davis A., et al. Wound healing complications after soft tissue sarcomas surgery. Plast Reconstr Surg 93 (1994) 980-987
65. Santoro A., Tursz T., Mouridsen H., et al. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 13 7 (1995) 1537-1545
66. Bramwell V., Rouesse J., Steward W., et al. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma-reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 12 6 (1994) 1137-1149
67. Collaboration SM-a. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet 350 9092 (1997) 1647-1654
68. Simon M., and Enneking W. The management of soft tissue sarcomas of the extremities. J Bone Joint Surg Am 58 (1976) 317-327
69. Basso-Ricci S. Therapy of malignant schwannomas: usefulness of an integrated radiologic surgical therapy. J Neurosurg Sci 33 (1989) 253-257
70. Collin C., Godbold J., Hajdu S., et al. Localized extremity soft tissue sarcoma: an analysis of factors affecting survival. J Clin Oncol 5 4 (1987) 601-612
71. Ghosh B.C., Ghosh L., Huvos A.G., et al. Malignant schwannoma. A clinicopathologic study. Cancer 31 1 (1973) 184-190
72. Murphey M., Smith W., Smith S., et al. Imaging of musculoskeletal neurogenic tumors: radiologic-pathologic correlation. Radiographics 19 (1999) 1253-1280
73. Pollock R. Neurogenic sarcomas: experience at the University of Toronto. [comment]. Neurosurgery 43 1 (1998) 65
74. Tanabe K.K., Pollock R.E., Ellis L.M., et al. Influence of surgical margins on outcome in patients with preoperatively irradiated extremity soft tissue sarcomas. Cancer 73 6 (1994) 1652-1659
75. Zelefsky M., Nori D., Shiu M., et al. Limb salvage in soft tissue sarcomas involving neurovascular structures using combined surgical resection and brachytherapy. Int J Radiat Oncol Biol Phys 19 (1990) 913-918
76. Sordillo P.P., Helson L., Hajdu S.I., et al. Malignant schwannoma-clinical characteristics, survival, and response to therapy. Cancer 47 10 (1981) 2503-2509